This inventor holds 1 USPTO granted patent and 5 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Amneal Pharmaceuticals LLC. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Vishalgiri Gunvantgiri Goswami: Innovator in Pain Treatment
Introduction
Vishalgiri Gunvantgiri Goswami is a notable inventor based in Ahmedabad, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address pain management. His innovative work has led to the creation of a patent that holds promise for therapeutic applications.
Latest Patents
Goswami holds a patent for "Compounds useful to treat pain." This invention relates to compounds that act as bradykinin receptor antagonists. The pharmaceutical composition he developed comprises these compounds and is intended for therapeutic use. The invention specifically targets the treatment of urinary bladder pain and provides symptomatic relief from pain, burning, urgency, frequency, and other discomforts caused by irritation of the lower urinary tract mucosa. This irritation may arise from various factors, including infection, trauma, surgery, endoscopic procedures, or the passage of sounds or catheters. He has 1 patent to his name.
Career Highlights
Goswami is currently associated with Amneal Pharmaceuticals LLC, where he continues to work on innovative solutions in the pharmaceutical industry. His expertise and dedication to research have positioned him as a valuable asset in his field.
Collaborations
Some of his notable coworkers include Heta Nishil Pandya and Sandip Pareshbhai Mehta. Their collaborative efforts contribute to the advancement of pharmaceutical research and development.
Conclusion
Vishalgiri Gunvantgiri Goswami is a prominent inventor whose work in pain treatment showcases the potential of innovative pharmaceutical solutions. His contributions are paving the way for improved therapeutic options in managing pain and discomfort.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
